Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Products

  Featured Products

Product News
PGDx Launches CancerSelect™ Targeted Gene Panel for Patients and Physicians
Friday, November 14, 2014
Company is first to offer highly informative panel that targets the most actionable cancer genes and compares tumor and normal DNA.

PGDx Launches CancerSelect™ ES Providing Turnkey Solution
Friday, November 14, 2014
Enterprise solution package for labs includes panels targeting most relevant cancer genes, bioinformatics software, report generation, staff training, technical support and gene panel updates.

BioCision Announces Industry’s First Automated Biospecimen Thawing System
Wednesday, November 12, 2014
Intelligent device utilizes adaptive sensing technology for accurate and standardized thawing.

Quest Diagnostics Introduces BRCAvantage Plus™
Friday, November 07, 2014
First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer.

EKF Molecular to Exhibit at AMP 2014
Friday, November 07, 2014
Senior executives on hand to discuss collaborative research with MGH aimed at developing routine blood based tests for cancer.

Product NewsProduct News
Scientific News
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
New Device Could Make Large Biological Circuits Practical
Innovation from MIT could allow many biological components to be connected to produce predictable effects.
Precisely Off The Mark
Possible cause discovered for failure of targeted liver cancer therapies.
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
New Test Developed at Dana-Farber/Brigham and Women's Cancer Center
Rapid Heme Panel - A high-tech genetic test that speeds treatment decisions for blood cancer patients.
Researchers Silence Leading Cancer-Causing Gene
A novel siRNA-based molecule successfully targets KRAS, a well-studied but hard to halt protein important for cancer development and metastasis.
Tumor Suppressor Also Inhibits Key Property Of Stem Cells
The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for pluripotency.
Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
P53 considered important biomarker for cancer drug discovery.
Next-Gen Melanoma Drug Excels in Lab Tests
Anti-cancer activity was reported in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733.
Study Identifying Cell of Origin for Large, Disfiguring Nerve Tumors
Lays groundwork for development of new therapies.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv